Melanoma is an aggressive form of skin cancer that originates in the pigment-producing cells known as melanocytes. Because of its potential to spread rapidly to other parts of the body, early detection is the most significant factor in a successful outcome. At Dermatology & Dermatologic Surgery Group of Northern Virginia, PLLC, in Vienna, VA, Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., perform detailed screenings to identify suspicious lesions before they evolve. Our specialists combine years of clinical experience with advanced diagnostic tools to monitor patients at elevated risk for this condition.
A thorough evaluation begins with a total body skin exam, during which the dermatologist inspects the skin from head to toe, including often-overlooked areas like the scalp, between the toes, and under the nails. During this process, Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., look for the "ugly duckling" sign, a mole that stands out as different from the surrounding spots in color, shape, or size. This visual baseline allows our Vienna, VA, team to track whether the mole changes, which is a key indicator that a pre-existing mole has become malignant.
To look beyond what is visible to the naked eye, our physicians employ dermoscopy. A dermatoscope is a specialized handheld instrument that provides high-magnification and polarized light to reveal the internal structures of a lesion, such as pigment networks and vascular patterns. This non-invasive tool helps Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., distinguish between benign atypical moles and early-stage melanoma. By analyzing the architectural symmetry and distribution of pigment, we can make more informed decisions about which lesions require a biopsy.
Evaluating melanoma risk also involves an analysis of a patient's history and biological characteristics. Individuals with a high mole count, a history of blistering sunburns, or fair skin that freckles easily are statistically more susceptible to skin cancer. Furthermore, having a first-degree relative with a history of melanoma significantly increases your personal risk profile. At our Vienna, VA, practice, we incorporate these details into a longitudinal care plan, ensuring that high-risk individuals receive the appropriate frequency of screenings to detect any irregularities at the earliest possible stage.
When a lesion meets the clinical criteria for suspicion, a biopsy is performed to obtain a definitive diagnosis. Our surgeons remove a sample of the tissue under local anesthesia and send it to a dermatopathologist for microscopic examination. This analysis determines the thickness of the melanoma, known as the Breslow depth, which is the most important predictor of its behavior.
Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., are dedicated to providing the residents of Northern Virginia with the highest standard of oncological skin care, emphasizing precision in both diagnosis and surgical intervention. If you have a suspicious lesion on your skin, schedule a consultation at our Vienna, VA, office by calling (703) 938-5700.
Melanoma is an aggressive form of skin cancer that originates in the pigment-producing cells known as melanocytes. Because of its potential to spread rapidly to other parts of the body, early detection is the most significant factor in a successful outcome. At Dermatology & Dermatologic Surgery Group of Northern Virginia, PLLC, in Vienna, VA, Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., perform detailed screenings to identify suspicious lesions before they evolve. Our specialists combine years of clinical experience with advanced diagnostic tools to monitor patients at elevated risk for this condition.
A thorough evaluation begins with a total body skin exam, during which the dermatologist inspects the skin from head to toe, including often-overlooked areas like the scalp, between the toes, and under the nails. During this process, Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., look for the "ugly duckling" sign, a mole that stands out as different from the surrounding spots in color, shape, or size. This visual baseline allows our Vienna, VA, team to track whether the mole changes, which is a key indicator that a pre-existing mole has become malignant.
To look beyond what is visible to the naked eye, our physicians employ dermoscopy. A dermatoscope is a specialized handheld instrument that provides high-magnification and polarized light to reveal the internal structures of a lesion, such as pigment networks and vascular patterns. This non-invasive tool helps Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., distinguish between benign atypical moles and early-stage melanoma. By analyzing the architectural symmetry and distribution of pigment, we can make more informed decisions about which lesions require a biopsy.
Evaluating melanoma risk also involves an analysis of a patient's history and biological characteristics. Individuals with a high mole count, a history of blistering sunburns, or fair skin that freckles easily are statistically more susceptible to skin cancer. Furthermore, having a first-degree relative with a history of melanoma significantly increases your personal risk profile. At our Vienna, VA, practice, we incorporate these details into a longitudinal care plan, ensuring that high-risk individuals receive the appropriate frequency of screenings to detect any irregularities at the earliest possible stage.
When a lesion meets the clinical criteria for suspicion, a biopsy is performed to obtain a definitive diagnosis. Our surgeons remove a sample of the tissue under local anesthesia and send it to a dermatopathologist for microscopic examination. This analysis determines the thickness of the melanoma, known as the Breslow depth, which is the most important predictor of its behavior.
Linda Park Nims, M.D., Rebecca Rudd Barry, M.D., and Kelley Pagliai Redbord, M.D., are dedicated to providing the residents of Northern Virginia with the highest standard of oncological skin care, emphasizing precision in both diagnosis and surgical intervention. If you have a suspicious lesion on your skin, schedule a consultation at our Vienna, VA, office by calling (703) 938-5700.
243 Church Street NW, Suite 200-C,
Vienna, VA 22180
Monday - Friday
9:00 am - 12:30 pm
1:30 pm - 4:30 pm
Saturday, Sunday
Closed